These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17115192)

  • 1. Treatment of steroid-resistant membranous lupus nephritis with plasmapheresis and low-dose cyclosporine.
    Fujinaga S; Ohtomo Y; Umino D; Mochizuki H; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
    Pediatr Nephrol; 2007 Apr; 22(4):616-7. PubMed ID: 17115192
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine (CsA) in lupus nephritis: assessing the evidence.
    Moroni G; Doria A; Ponticelli C
    Nephrol Dial Transplant; 2009 Jan; 24(1):15-20. PubMed ID: 18852191
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral lupus in patients whilst on treatment for lupus nephritis with cyclosporine.
    Hussein M; Mooij J; Roujouleh H
    J Clin Neurosci; 2003 Jan; 10(1):104-6. PubMed ID: 12464536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.
    Ferrario L; Bellone M; Bozzolo E; Baldissera E; Sabbadini MG
    Rheumatology (Oxford); 2000 Feb; 39(2):218-220. PubMed ID: 10725082
    [No Abstract]   [Full Text] [Related]  

  • 5. [Response to mycophenolate mofetil in a case of lupus nephropathy resistant to cyclophosphamide IV and cyclosporin A].
    Navas-Parejo A; Espigares MJ; Alhosni A; García-Valdecasas J
    Nefrologia; 2001; 21(5):516-7. PubMed ID: 11795027
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
    Fu YF; Liu GL
    Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options for resistant lupus nephritis.
    Mok CC
    Semin Arthritis Rheum; 2006 Oct; 36(2):71-81. PubMed ID: 16884971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of steroid-resistant systemic lupus erythematosus with extremely low dose of cyclosporine A.
    Sakano T; Ohta T; Kinoshita Y; Fjiwara M; Wakai M
    Pediatr Int; 2004 Aug; 46(4):468-70. PubMed ID: 15310316
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
    Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
    Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of membranous lupus nephritis: where are we now?
    Beck LH; Salant DJ
    J Am Soc Nephrol; 2009 Apr; 20(4):690-1. PubMed ID: 19279123
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine treatment of glomerular diseases.
    Klein M; Radhakrishnan J; Appel G
    Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options in lupus nephritis.
    McLigeyo SO
    East Afr Med J; 1998 Oct; 75(10):609-13. PubMed ID: 10065198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine treatment of lupus membranous nephropathy.
    Radhakrishnan J; Kunis CL; D'Agati V; Appel GB
    Clin Nephrol; 1994 Sep; 42(3):147-54. PubMed ID: 7994932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cyclosporin in lupus nephritis.
    Radhakrishnan J; Valeri A; Kunis C; Appel GB
    Contrib Nephrol; 1995; 114():59-72. PubMed ID: 7587199
    [No Abstract]   [Full Text] [Related]  

  • 15. Ciclosporin A in lupus nephritis.
    Erdem Y; Yalçin AU; Oymak O; Yasavul U; Turgan C; Cağlar S
    Nephron; 1996; 72(2):332. PubMed ID: 8684556
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective multicentre trial on the short-term effects of plasma exchange versus cytotoxic drugs in steroid-resistant lupus nephritis.
    Derksen RH; Hené RJ; Kallenberg CG; Valentijn RM; Kater L
    Neth J Med; 1988 Oct; 33(3-4):168-77. PubMed ID: 3067098
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranous lupus nephritis.
    Austin HA; Illei GG
    Lupus; 2005; 14(1):65-71. PubMed ID: 15732291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience.
    Yap DY; Ma MK; Tang CS; Chan TM
    Nephrology (Carlton); 2012 Nov; 17(8):676-80. PubMed ID: 22817609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
    Yamaji K; Kim YJ; Tsuda H; Takasaki Y
    Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
    Tse KC; Lam MF; Tang SC; Tang CS; Chan TM
    Lupus; 2007; 16(1):46-51. PubMed ID: 17283585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.